Acute myocardial infarction: Safety of cardiac MR imaging after percutaneous revascularization with stents

Manesh R. Patel, Timothy S.E. Albert, David E. Kandzari, Emily F. Honeycutt, Linda K. Shaw, Michael H. Sketch, Michael D. Elliott, Robert M. Judd, Raymond J. Kim

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


Purpose: To retrospectively determine the safety of cardiac magnetic resonance (MR) imaging performed early (<14 days) after coronary stent implantation in patients with acute myocardial infarction (AMI). Materials and Methods: This HIPPA-compliant study was approved by the institutional review board; the informed consent requirement was waived. Consecutive patients with AMI who underwent cardiac MR imaging (study group) shortly after stent implantation (median, 3 days) were compared with control subjects who did not undergo MR imaging and were matched for clinical factors and angiographic extent of coronary disease. A 1.5-T MR imager was used to evaluate cine function, perfusion, and viability. Rates of death, non-fatal myocardial infarction, or revascularization 30 days and 6 months after stent implantation were compared with χ2 analysis. Results: The study group consisted of 66 patients (median age, 56 years; 17 women.) with 97 stents, 38 (39%) of which were drug eluting. The control group included 124 patients (median age, 58 years; 23% women) with 197 stents, 21 (10.7%) of which were drug eluting. There was no significant (P = .13) difference in the combined end point of death, nonfatal myocardial infarction, or revascularization between the study (2.0% [95% confidence interval: 0.0%, 4.5%]) and control (6.5% [95%. confidence interval: 1.6%, 11.3%]) groups at 30-day follow-up. The event-free survival rate at 6-month follow-up was 91% in the study group and 83.7% in the control group (P = .18). Considering the end points separately, there was no difference in the event rate at 30-day or 6-month follow-up between groups. No adverse cardiovascular events occurred in patients with drug-eluting stents who underwent MR imaging. Conclusion: Cardiac MR imaging performed shortly after AMI and percutaneous revascularization with bare metal or drug-eluting stents appears safe. The risk of adverse cardiovascular events is low and similar to that in patients who do not undergo MR imaging.

Original languageEnglish (US)
Pages (from-to)674-680
Number of pages7
Issue number3
StatePublished - Sep 2006

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Acute myocardial infarction: Safety of cardiac MR imaging after percutaneous revascularization with stents'. Together they form a unique fingerprint.

Cite this